Subcutaneous alemtuzumab may be useful in the treatment of steroid-refractory acute graft-versus-host disease

被引：0
|
作者：
Gomez-Almaguer, David [1 ]
Ruiz-Arguelles, Guillermo J. [2 ]
Gonzalez-Llano, Oscar [1 ]
Guttierez-Aguire, Homero C. [1 ]
Cantu-Rodriguez, Olga G. [1 ]
Jaime-Perez, Jose C. [1 ]
Giralt, Sergio [3 ]
机构：
[1] Hosp Univ, Monterrey, Mexico
[2] Ctr Hematol & Med Interna Puebla, Puebla, Mexico
[3] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2983.2983
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2983
引用
收藏
页码：876A / 876A
页数：1
相关论文
共 50 条
  • [1] Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillenmo J.
    Tarin-Arzaga, Luz del Carmen
    Gonzalez-Llano, Oscar
    Gutierrez-Aguirre, Homero
    Cantu-Rodriguez, Olga
    Jaime-Perez, Jose
    Carrasco-Yalan, Antonio
    Giralt, Sergio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 10 - 15
  • [2] Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
    Meunier, Mathieu
    Bulabois, Claude Eric
    Thiebaut-Bertrand, Anne
    Itzykson, Raphael
    Carre, Martin
    Carras, Sylvain
    Garban, Frederic
    Cahn, Jean Yves
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1451 - 1454
  • [3] Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study
    Martinez, Carmen
    Solano, Carlos
    Ferra, Christelle
    Sampol, Antonio
    Valcarcel, David
    Antonio Perez-Simon, Jose
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (05) : 639 - 642
  • [4] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [5] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [6] The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients
    Khandelwal, Pooja
    Lawrence, Julia
    Filipovich, Alexandra H.
    Davies, Stella M.
    Bleesing, Jacob J.
    Jordan, Michael B.
    Mehta, Parinda
    Jodele, Sonata
    Grimley, Michael S.
    Kumar, Ashish
    Myers, Kasiani
    Marsh, Rebecca A.
    PEDIATRIC TRANSPLANTATION, 2014, 18 (01) : 94 - 102
  • [7] Low dose alemtuzumab is effective in the treatment of severe steroid-refractory acute graft-versus-host disease
    Repp, R
    Claviez, A
    Gahn, B
    Schub, N
    Beck, C
    Helm, F
    Gramatzki, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S97 - S97
  • [8] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
  • [9] Alemtuzumab as treatment of steroid-refractory acute graft-versus-host disease: results of a phase II study
    Martinez, C.
    Solano, C.
    Ferra, C.
    Sampol, A.
    Valcarcel, D.
    Perez-Simon, J. A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S132 - S132
  • [10] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
12345